PTN Palatin Technologies, Inc. Comm

0.44
-0.01  -2.03%
Previous Close 0.45
Open 0.46
Price To book 0.00
Market Cap 47.66M
Shares 108,039,000
Volume 3,341,211
Short Ratio 0.80
Av. Daily Volume 3,067,180

SEC filingsSee all SEC filings

  1. 8-K - Current report 17515868
  2. 424B5 - Prospectus [Rule 424(b)(5)] 162029414
  3. 8-K - Current report 162029082
  4. 424B5 - Prospectus [Rule 424(b)(5)] 162025472
  5. S-8 - Securities to be offered to employees in employee benefit plans 161999861

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

NDA filing due early 2018.
Rekynda
Female sexual dysfunction (FSD)
Phase 2 planned for 1H 2017
PL-3994
Heart failure

Latest News

  1. Palatin Technologies to Hold Call Following Closing of Licensing Agreement for North American Rights to Rekynda™
  2. AMAG Pharmaceuticals, Inc. (AMAG), Palatin Technologies, Inc. (PTN) In Licensing Deal
  3. AMAG, Palatin Ink Deal to Focus on Female Sexual Disorder
  4. Why AMAG Pharmaceuticals, Inc. Is Falling Today
  5. PALATIN TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement
  6. AMAG Pharmaceuticals and Palatin Technologies Enter Into Exclusive Licensing Agreement for North American Rights to Rekyndatm (bremelanotide), a Potential Treatment for a Common Female Sexual Disorder
  7. AMAG Pharmaceuticals and Palatin Technologies Enter Into Exclusive Licensing Agreement for North American Rights to Rekynda™ (bremelanotide), a Potential Treatment for a Common Female Sexual Disorder
  8. How CytRx Corporation (CYTR) Stacks Up Against Its Peers
  9. Palatin Technologies Closes on $16.5 Million Financing
  10. PALATIN TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement
  11. Palatin Technologies Announces Proposed Public Offering of Common Stock and Warrants
  12. Palatin Technologies Announces Pricing of Public Offering of Common Stock and Warrants
  13. Palatin Technologies, Inc. :PTN-US: Earnings Analysis: Q1, 2017 By the Numbers : December 1, 2016
  14. Palatin Technologies Announces Pricing of Public Offering of Common Stock and Warrants
  15. Palatin Technologies Announces Proposed Public Offering of Common Stock and Warrants
  16. PALATIN TECHNOLOGIES INC Financials
  17. PALATIN TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition
  18. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2017 Results; Teleconference and Webcast to be held on November 15, 2016
  19. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2017 Results; Teleconference and Webcast to be held on November 15, 2016
  20. PALATIN TECHNOLOGIES INC Files SEC form 10-Q, Quarterly Report

SEC Filings

  1. 8-K - Current report 17515868
  2. 424B5 - Prospectus [Rule 424(b)(5)] 162029414
  3. 8-K - Current report 162029082
  4. 424B5 - Prospectus [Rule 424(b)(5)] 162025472
  5. S-8 - Securities to be offered to employees in employee benefit plans 161999861
  6. 8-K - Current report 161997939
  7. 10-Q - Quarterly report [Sections 13 or 15(d)] 161995641
  8. 8-K - Current report 161965919
  9. CT ORDER - Confidential treatment order 161944906
  10. 8-K - Current report 161893033